FluoretiQ patent granted to enable fast and accurate antibiotic testing

FluoretiQ founders smiling with technology on PC

Bristol-based biotech company, FluoretiQ, who is developing fast and accurate point-of-care testing for Urinary Tract Infections (UTIs) and Sexually Transmitted Diseases (STDs), has taken a significant step forward after having a key patent granted. The University of Bristol spinout joined our incubation programme in 2021 with the vision of enabling more targeted antibiotic use and mitigating…

Read More

HealthTech cluster flourishing at SETsquared Bristol

HealthTech is a hot topic. Lack of technology has long been a frustration for healthcare professionals, but progress in the artificial intelligence (AI), blockchain, voice activation, and virtual reality (VR) industries are generating promising results in HealthTech, leading to streamlined operations, lowered costs, and increased quality of care for patients. From telemonitoring to DNA testing,…

Read More